[{"id":"ed3db04e-b024-46dd-be65-5b890e31ae22","acronym":"","url":"https://clinicaltrials.gov/study/NCT02793856","created_at":"2021-03-23T07:05:29.399Z","updated_at":"2024-07-02T16:36:36.208Z","phase":"Phase 1","brief_title":"PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer","source_id_and_acronym":"NCT02793856","lead_sponsor":"Sichuan University","biomarkers":" EGFR • ALK • PD-1 • IL6 • TNFA • IL10","pipe":" | ","alterations":" ALK positive","tags":["EGFR • ALK • PD-1 • IL6 • TNFA • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • PD-1-KO-T cell injection • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 08/26/2016","start_date":" 08/26/2016","primary_txt":" Primary completion: 08/20/2018","primary_completion_date":" 08/20/2018","study_txt":" Completion: 03/17/2020","study_completion_date":" 03/17/2020","last_update_posted":"2021-01-12"}]